Glucocorticoid_NN
receptor_NN
binding_NN
in_IN
three_CD
different_JJ
cell_NN
types_NNS
in_IN
major_JJ
depressive_JJ
disorder_NN
:_:
lack_NN
of_IN
evidence_NN
of_IN
receptor_NN
binding_NN
defect_NN
._.

1_LS
._.
In_IN
order_NN
to_TO
further_RB
understand_VB
the_DT
apparent_JJ
glucocorticoid_NN
resistance_NN
in_IN
major_JJ
depressive_JJ
disorder_NN
,_,
circadian_JJ
variation_NN
in_IN
cortisol_NN
concentration_NN
,_,
dexamethasone_NN
suppression_NN
and_CC
glucocorticoid_NN
receptor_NN
binding_NN
in_IN
mononuclear_JJ
leukocytes_NNS
,_,
polymorphonuclear_JJ
leukocytes_NNS
and_CC
cultured_VBN
skin_NN
fibroblasts_NNS
were_VBD
measured_VBN
in_IN
rigidly_RB
defined_VBN
major_JJ
depressive_JJ
disorder_NN
patients_NNS
and_CC
non-depressed_JJ
psychiatric_JJ
controls_NNS
._.

2_LS
._.
Mononuclear_JJ
leukocytes_NNS
binding_VBG
to_TO
glucocorticoid_NN
correlated_VBD
significantly_RB
with_IN
polymorphonuclear_JJ
leukocytes_NNS
binding_VBG
to_TO
glucocorticoid_NN
,_,
but_CC
both_DT
determinations_NNS
failed_VBD
to_TO
differentiate_VB
major_JJ
depressive_JJ
disorder_NN
and_CC
control_NN
subjects_NNS
._.

3_LS
._.
Initial_JJ
and_CC
post-dexamethasone_JJ
in_FW
vitro_FW
fibroblast_NN
binding_NN
to_TO
glucocorticoid_NN
was_VBD
not_RB
different_JJ
between_IN
major_JJ
depressive_JJ
disorder_NN
and_CC
non-depressed_JJ
control_NN
subjects_NNS
._.

4_LS
._.
The_DT
phenomenon_NN
of_IN
glucocorticoid_NN
resistance_NN
in_IN
major_JJ
depressive_JJ
disorder_NN
remains_VBZ
unexplained_JJ
._.

